Free Trial

UiPath Inc. (NYSE:PATH) Stake Raised by Public Employees Retirement System of Ohio

UiPath logo with Business Services background

Public Employees Retirement System of Ohio increased its position in shares of UiPath Inc. (NYSE:PATH - Free Report) by 61.9% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 240,123 shares of the company's stock after purchasing an additional 91,788 shares during the period. Public Employees Retirement System of Ohio's holdings in UiPath were worth $3,074,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of PATH. Pacer Advisors Inc. purchased a new position in shares of UiPath during the 2nd quarter worth about $69,180,000. Jacobs Levy Equity Management Inc. boosted its position in UiPath by 554.8% in the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 4,026,502 shares of the company's stock valued at $51,539,000 after buying an additional 3,411,562 shares during the period. Senvest Management LLC boosted its position in UiPath by 16.7% in the 3rd quarter. Senvest Management LLC now owns 10,894,483 shares of the company's stock valued at $139,449,000 after buying an additional 1,559,500 shares during the period. Worldquant Millennium Advisors LLC purchased a new stake in shares of UiPath in the 3rd quarter worth approximately $19,071,000. Finally, Renaissance Technologies LLC purchased a new stake in shares of UiPath in the 2nd quarter worth approximately $13,280,000. 62.50% of the stock is currently owned by institutional investors.

UiPath Price Performance

Shares of NYSE PATH traded down $0.15 during midday trading on Tuesday, reaching $13.91. 5,964,170 shares of the company traded hands, compared to its average volume of 9,672,439. UiPath Inc. has a 52 week low of $10.37 and a 52 week high of $27.87. The stock has a 50-day moving average price of $13.39 and a 200 day moving average price of $12.61. The company has a market cap of $7.64 billion, a price-to-earnings ratio of -86.94 and a beta of 0.94.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on PATH. Barclays upped their price target on shares of UiPath from $15.00 to $16.00 and gave the stock an "equal weight" rating in a research report on Friday, December 6th. Evercore ISI upped their price target on shares of UiPath from $13.00 to $16.00 and gave the stock an "in-line" rating in a research report on Friday, September 6th. DA Davidson upped their price target on shares of UiPath from $13.00 to $15.00 and gave the stock a "neutral" rating in a research report on Friday, September 6th. Morgan Stanley boosted their price objective on shares of UiPath from $15.00 to $16.00 and gave the stock an "equal weight" rating in a research note on Friday, December 6th. Finally, UBS Group started coverage on shares of UiPath in a research note on Thursday, December 12th. They set a "sell" rating and a $14.00 price objective for the company. One equities research analyst has rated the stock with a sell rating, sixteen have issued a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat.com, UiPath has a consensus rating of "Hold" and an average price target of $17.50.

View Our Latest Research Report on PATH

About UiPath

(Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

See Also

Institutional Ownership by Quarter for UiPath (NYSE:PATH)

Should you invest $1,000 in UiPath right now?

Before you consider UiPath, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.

While UiPath currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Unveils Game-Changing Tech, But Stock Dips
Rivian Stock Surge Analysis: Long-Term Potential or Short-Term Play?
The Future of Healthcare: 3 AI Stocks Leading the Way

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines